Tetrahydropyridothiophenes for use in the treatment of cancer

US7517986B2 · kind B2 · utility

Assignee

• 4SC AG · DE

Inventors

• Klaus Pekari · Radolfzell, DE
• Thomas Baer · Edgerton, US
• Mathias Schmidt · Idstein, DE
• Thomas Beckers · Konstanz, DE

Key dates

• Filing date: Jun 3, 2005
• Grant date: Apr 14, 2009
• Expiry date: Jul 11, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula (I)in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.